Association between intravenous amino acid/lipid emulsion and prognosis: a cohort study using medical claims database

Association between intravenous amino acid/lipid emulsion and prognosis: a cohort study using medical claims database - Intravenous amino acid/lipid and prognosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044962

Enrollment

100000

Registered

2021-07-27

Start date

2021-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who received parenteral nutrition

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Hospitalized patient (January 2011 to September 2020) (2) Fasting for more than 10 consecutive days

Exclusion criteria

Exclusion criteria: (1) Surgery (day of hospitalization to 10 days after fasting) (2) Intensive care unit (day of hospitalization to 10 days after fasting) (3) Intravenous mean energy dose <10 kcal/kg (4 to10 days after fasting) (4) Intravenous mean energy dose >=30 kcal/kg(4 to 10 days after fasting) (5) Intravenous mean amino acid dose <0.5 g/kg(4 to 10 days after fasting) * * Only when investigating the association between intravenous lipid and prognosis

Design outcomes

Primary

Measure	Time frame
In-hospital mortality	—

Secondary

Measure	Time frame
(1) Catheter infection (2) Activities of daily living (3) Re-admission (4) Length of stay (5) Medical costs	—

Countries

Japan

Contacts

Public ContactSatoru Kamoshita

Otsuka Pharmaceutical Factory, Inc. Medical Affairs Department

kamoshitas@otsuka.jp03-5217-5954

Outcome results